In DS, elevated plasma B2M crosses the BBB and suppresses N-methyl-D-aspartate (NMDA) receptor activity, disrupting synaptic excitatory/inhibitory homeostasis and precipitating cognitive dysfunction [87]. Here, B2M is linked to Dravet syndrome.